Astrana Health (ASTH) Stock Statistics & Valuation Metrics

Astrana Health has a market cap or net worth of $1.71B. The enterprise value is $2.13B.

Market Cap

$1.71B

Enterprise Value

$2.13B

Astrana Health has 49,604,366 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

49,604,366

Owned by Insiders

36.11%

Owned by Institutions

46.79%

Astrana Health’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.88%.

Return on Equity (ROE)

0.03

Return on Assets (ROA)

0.01

Return on Invested Capital (ROIC)

2.88%

Return on Capital Employed (ROCE)

0.05

Revenue Per Employee

1.06M

Profits Per Employee

7,495.667

Employee Count

3,000

Asset Turnover

1.43

Inventory Turnover

0.00

The current PE Ratio of Astrana Health is 31.94. Astrana Health’s PEG ratio is 0.07.

PE Ratio

31.94

PS Ratio

0.44

PB Ratio

1.98

Price to FCF

10.47

Price to Operating Cash Flow

9.32

PEG Ratio

0.07

In the last 12 months, Astrana Health had revenue of 3.18B and earned 22.49M in profits. Earnings per share was 0.46.

Revenue

3.18B

Gross Profit

295.78M

Operating Income

78.53M

Pretax Income

39.61M

Net Income

22.49M

EBITDA

135.28M

Earnings Per Share (EPS)

0.46

In the last 12 months, operating cash flow was 182.25M and capital expenditures -18.77M, giving a free cash flow of 163.47M billion.

Operating Cash Flow

182.25M

Free Cash Flow

163.47M

Free Cash Flow per Share

3.32

Astrana Health pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

9.55%

Earnings Yield

3.13%

Beta

1.07

52-Week Price Change

3.42%

50-Day Moving Average

36.99

200-Day Moving Average

34.27

Relative Strength Index (RSI)

39.82

Average Volume (3m)

382.49K

Astrana Health upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Feb 25, 2027

Ex-Dividend Date

―

Astrana Health as a current ratio of 1.40, with Debt / Equity ratio of 138.35%

Current Ratio

1.40

Quick Ratio

1.40

Debt to Market Cap

0.85

Net Debt to EBITDA

4.79

Interest Coverage Ratio

1.57

In the past 12 months, Astrana Health has paid 15.53M in taxes.

Income Tax

15.53M

Effective Tax Rate

0.39

Astrana Health EV to EBITDA ratio is 10.70, with an EV/FCF ratio of 14.02.

EV to Sales

0.59

EV to EBITDA

10.70

EV to Free Cash Flow

14.02

EV to Operating Cash Flow

12.58

Astrana Health has $396.23M in cash and marketable securities with $977.38M in debt, giving a net cash position of -$581.16M billion.

Cash & Marketable Securities

$396.23M

Total Debt

$977.38M

Net Cash

-$581.16M

Net Cash Per Share

-$11.72

Tangible Book Value Per Share

-$9.90

Gross margin is 8.00%, with operating margin of 3.10%, and net profit margin of 1.36%.

Gross Margin

8.00%

Operating Margin

3.10%

Pretax Margin

2.22%

Net Profit Margin

1.36%

EBITDA Margin

5.48%

EBIT Margin

3.87%

The average price target for Astrana Health is $51.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

$51.50

Price Target Upside

49.28% Upside

Analyst Consensus

Strong Buy

Analyst Count

6

Revenue Growth Forecast

35.05%

EPS Growth Forecast

463.11%

Smart Score

8

AI Score

60